JPH0359911B2 - - Google Patents
Info
- Publication number
- JPH0359911B2 JPH0359911B2 JP13472485A JP13472485A JPH0359911B2 JP H0359911 B2 JPH0359911 B2 JP H0359911B2 JP 13472485 A JP13472485 A JP 13472485A JP 13472485 A JP13472485 A JP 13472485A JP H0359911 B2 JPH0359911 B2 JP H0359911B2
- Authority
- JP
- Japan
- Prior art keywords
- ss48727e
- physiologically active
- strain
- active substance
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000013543 active substance Substances 0.000 claims description 26
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 241000187747 Streptomyces Species 0.000 claims description 7
- 241000970912 Streptomyces pactum Species 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 230000001580 bacterial effect Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- BBLGCDSLCDDALX-LKGBESRRSA-N piericidin A Chemical group COC=1NC(C\C=C(/C)C\C=C\C(\C)=C\[C@@H](C)[C@@H](O)C(\C)=C\C)=C(C)C(=O)C=1OC BBLGCDSLCDDALX-LKGBESRRSA-N 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000012136 culture method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 3
- 229910000365 copper sulfate Inorganic materials 0.000 description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 3
- 239000000287 crude extract Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 229940099596 manganese sulfate Drugs 0.000 description 3
- 239000011702 manganese sulphate Substances 0.000 description 3
- 235000007079 manganese sulphate Nutrition 0.000 description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 3
- 229940120668 salicin Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 description 3
- 229960001763 zinc sulfate Drugs 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930182661 Piericidin Natural products 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 108010009004 proteose-peptone Proteins 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- -1 soybean flour Natural products 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZQLBCAUKNYXILZ-UGKGYDQZSA-N Piericidin A Natural products COc1nc(CC=C(/C)C=CCC(=C[C@H](C)[C@@H](O)C(=CC)C)C)c(C)c(O)c1OC ZQLBCAUKNYXILZ-UGKGYDQZSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241000946911 Streptomyces karnatakensis Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-VAYJURFESA-N aldehydo-L-arabinose Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VAYJURFESA-N 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002897 organic nitrogen compounds Chemical class 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Description
〔産業上の利用分野〕
本発明は新規生理活性物質SS48727E及びその
製造法に関する。
〔従来の技術〕
従来、微生物が種々の生理活性物質を生産する
ことが知られている。例えばストレプトミセスパ
クタム0−1−10(Streptomyces pactum0−1
−10)はピエリシジン群(piericidins)の化合物
等を生産することが知られている〔高橋信孝ら,
アグリカルチヤル・アンド・バイオロジカルケミ
ストリー(Agricultural and Biological
Chemistry),41巻,849〜853頁及び855〜862頁
(1977年);高橋信孝ら、特開昭50−132183号〕。
〔発明が解決しようとする問題点〕
本発明は医薬、動物薬、農薬、試薬あるいはそ
れらへの変換素材として、有用な新規物質を提供
することを目的とする。
〔問題点を解決するための手段〕
本発明者らは天然の土壌より数多くの微生物を
単離し、その生産物について種々研究を行つた結
果、福島県双葉郡浪江町の土壌から分離した菌株
が、新規なピエリシジン群の生理活性物質
SS48727Eを生産することを見出し、本発明を完
成した。
すなわち本発明は新規生理活性物質SS48727E
及びその製造法を提供するものである。
本発明の生理活性物質SS48727Eを生産する菌
株、S48727株は次のような菌学的性質を有する。
(1) 形態
各種寒天培地で10〜14日間、28℃で培養し、
S48727株の形態を光学顕微鏡あるいは電子顕
微鏡で観察した結果以下の特徴を示した。
気菌糸より胞子形成菌糸が単純分枝し、その
先端部はらせん形である。輪生糸は認められな
い。成熟した分生胞子は、10個以上が連鎖し、
胞子の形は、短円筒形〜楕円形で、その大きさ
は、0.5〜0.8×0.7〜1.4μmである。胞子表面構
造は、毛状である。胞子のう、鞭毛胞子、菌核
はいずれも認められない。また、基中菌糸の分
断も認められない。
(2) 各種寒天培地における生育状態
S48727株の各種培地での生育状態は次表の
とおりである。観察は28℃、14日間培養後に行
つた。なお、色の記載は日本色研事業(株)発行
(昭和56年)「色名小事典」の系統色名で行つ
た。また、表中括弧内は色標番号を示す。
[Industrial Application Field] The present invention relates to a novel physiologically active substance SS48727E and a method for producing the same. [Prior Art] It has been known that microorganisms produce various physiologically active substances. For example, Streptomyces pactum 0-1-10 (Streptomyces pactum0-1
-10) is known to produce compounds of the piericidins group [Nobutaka Takahashi et al.
Agricultural and Biological Chemistry
Chemistry), Vol. 41, pp. 849-853 and pp. 855-862 (1977); Nobutaka Takahashi et al., JP-A No. 132183/1983]. [Problems to be Solved by the Invention] An object of the present invention is to provide a new substance useful as a medicine, an animal drug, an agricultural chemical, a reagent, or a material for conversion thereto. [Means for solving the problem] The present inventors isolated a large number of microorganisms from natural soil and conducted various studies on their products. As a result, a strain isolated from soil in Namie Town, Futaba District, Fukushima Prefecture was , a novel physiologically active substance of the piericidin group
It was discovered that SS48727E could be produced and the present invention was completed. That is, the present invention relates to a novel physiologically active substance SS48727E.
and a manufacturing method thereof. The strain S48727 that produces the physiologically active substance SS48727E of the present invention has the following mycological properties. (1) Morphology Cultured on various agar media at 28℃ for 10 to 14 days,
The morphology of the S48727 strain was observed using an optical microscope or an electron microscope, and the results showed the following characteristics. The spore-forming hyphae are simply branched from the aerial hyphae, and their tips are spiral-shaped. Ring-grown silk is not permitted. Mature conidia are a chain of 10 or more,
The shape of the spore is short cylindrical to oval, and its size is 0.5 to 0.8 x 0.7 to 1.4 μm. The spore surface structure is hair-like. No sporangia, flagellated spores, or sclerotia are observed. In addition, no division of basal hyphae was observed. (2) Growth status on various agar media The growth status of strain S48727 on various media is shown in the table below. Observations were made after culturing at 28°C for 14 days. The colors are described using the systematic color names from the "Small Dictionary of Color Names" published by Nippon Shikiken Business Co., Ltd. (1981). In addition, the number in parentheses in the table indicates the color standard number.
【表】
(3) 生理活性物質
生育温度範囲(イースト・麦芽寒天培地、
14日間培養)
生育至適温度 26〜34℃
生育可能温度 18〜37℃
ゼラチンの液化 陽 性
スターチの加水分解 陽 性
脱脂牛乳の凝固 陽 性
脱脂牛乳のペプトン化 陽 性
メラニン様色素の生成 陰 性
硝酸塩の還元 陰 性
セルロースの分解 陰 性
(4) 炭素源の同化性(プリドハム・ゴツトリーブ
寒天培地、28℃、14日間培養)
D−グルコース、ラフイノース、ガラクトー
スを利用し、サリシンも微弱に利用する。L−
アラビノース、D−キシロース、D−フラクト
ース、シユクロース、イノシトール、L−ラム
ノース、D−マンニツト、セルロース、ラクト
ース、D−ソルビトール、D−マンノース、イ
ヌリンは利用しない。
(5) 全菌体中のジアミノピメリン酸
全菌体中のジアミノピメリン酸を分析した結
果、LL−ジアミノピメリン酸を検出した。
以上の形態的特徴及びLL−ジアミノピメリン
酸を含むことより、S48727株は、ストレプトミ
セス属を属する一菌株であると判断される。
S48727株の菌学的性質を要約すると、次のよ
うになる。気菌糸の先端はらせん形で、その分生
胞子は10個以上の胞子が連鎖しその個々の胞子表
面は毛状である。気菌糸の色調はグレーカラーシ
リーズ、裏面の色は無色からイエローまたはブラ
ウンで、オートミール寒天培地ではグリーンがか
つたイエローを認める。可溶性色素は認められ
ず、メラニン様色素も生成しない。
以上の諸性質をもとに、シヤーリングとゴツト
リーブのISP報告「インターナシヨナル・ジヤー
ナル・オブ・システマテイツク・バクテリオロジ
ー(International Journal of Systematic
Bacteriology)」第18巻,69頁,279頁,(1968
年),同19巻,391頁(1969年),同22巻,265頁,
(1972年)及び「バージーズ・マニユアル・オ
ブ・デイターミネイテイブ・バクテリオロジー
(Bergey′sManual of Determinative
Bacteriology)」第8版より検索した結果、スト
レプトミセス カルナタケンシス
(Streptomyces karnatakensis)とストレプトミ
セス パクタム(Streptomyces pactum)が、
S48727株の近縁種として挙げられる。これら2
菌株との比較を行つた結果を次の表に示す。[Table] (3) Physiologically active substances Growth temperature range (yeast/malt agar medium,
(Culture for 14 days) Optimum temperature for growth: 26-34°C Growth temperature: 18-37°C Liquefaction of gelatin Positive Hydrolysis of starch Positive Coagulation of skim milk Positive Peptonization of skim milk Positive Production of melanin-like pigment Negative Nitrate reduction Negative Cellulose decomposition Negative (4) Carbon source assimilation (Pridham-Gottlieb agar medium, 28℃, 14 days culture) D-glucose, raffinose, galactose are used, and salicin is also used to a small extent. L-
Arabinose, D-xylose, D-fructose, sucrose, inositol, L-rhamnose, D-mannite, cellulose, lactose, D-sorbitol, D-mannose, and inulin are not used. (5) Diaminopimelic acid in all bacterial cells As a result of analyzing diaminopimelic acid in all bacterial cells, LL-diaminopimelic acid was detected. Based on the above morphological characteristics and containing LL-diaminopimelic acid, strain S48727 is judged to be a strain belonging to the genus Streptomyces. The mycological properties of strain S48727 can be summarized as follows. The tips of the aerial hyphae are spiral-shaped, and the conidia consist of 10 or more spores linked together, and the surface of each spore is hair-like. The color tone of the aerial mycelium is gray color series, and the color of the underside is colorless to yellow or brown, and on oatmeal agar medium, yellow with green is observed. No soluble pigments are observed and no melanin-like pigments are produced. Based on the above properties, Schearling and Gottlieb's ISP report “International Journal of Systematic Bacteriology”
Bacteriology) Volume 18, pp. 69, 279, (1968
), Vol. 19, p. 391 (1969), Vol. 22, p. 265,
(1972) and Bergey’s Manual of Determinative Bacteriology.
As a result of searching from the 8th edition of "Bacteriology", Streptomyces karnatakensis and Streptomyces pactum are
It is listed as a close relative of strain S48727. These 2
The results of comparison with bacterial strains are shown in the table below.
【表】【table】
【表】
炭素源の利用において、+は利用する、±は微弱に利
用する、−は利用しない。
上表にみられるようにS48727株と、ストレプ
トミセス カルナタケンシスIFO 13051株とは、
気菌糸の色調、ラフイノース、D−フラクトー
ス、サリシンの利用能及びリンゴ酸・石灰の利用
能の点で異なる。一方、ストレプトミセスパクタ
ム IFO 13433株とは、ラフイノース、D−フラ
クトース、サリシンの利用能で異なるが、他の菌
学的性状がほぼ一致する。したがつて、S48727
株は、ストレプトミセス パクタムに属する一菌
株であると同定した。また、S48727株は上述し
た菌学的性質及びピエリシジンA1(Piericidin
A1)を生産することから、ストレプトミセス
パクタム0−1−10(Streptomyces pactum0−
1−10)〔高橋信孝ら、アグリカルチヤル・アン
ド・バイオロジカルケミストリー,41巻,849〜
853頁及び855〜862頁,(1977年)〕、〔高橋信孝ら、
特開昭50−132183号〕との近縁関係が示唆され
る。しかしながら0−1−10株は本願目的化合物
を生産しないので、S48727株はこれと別異な新
しい菌株と判断される。
したがつて、本発明者は、S48727株を公知の
菌株と区別するために、ストレプトミセス パク
タム S48727(Streptomyces pactumS48727)と
命名し、工業技術院微生物工業技術研究所に受託
番号微工研菌寄第8117号(FERM P−8117)と
して寄託した。
本発明の生理活性物質SS48727Eは上記菌株を
栄養源含有培地に接種し、好気的に培養すること
により製造される。生理活性物質SS48727E生産
株としては、上記S48727株はもとより、その人
工変異株あるいは自然変異株であつても生理活性
物質SS48727Eを生産する能力を有するものであ
ればすべて本発明に使用することができる。上記
S48727株の人工変異株は、他の放線菌の場合と
同様、例えば紫外線照射、コバルト60照射、化学
変異誘起剤処理等により容易に得ることができ
る。
次に、生理活性物質SS48727Eの製造における
菌株の培養について説明する。すなわち、ストレ
プトミセス属に属する生理活性物質SS48727E生
産株の培養には通常の放射菌の培養法が用いられ
る。栄養培地としては、資化しうる炭素源、窒素
源、無機物などを適当に含有する限り、合成培
地、半合成培地あるいは天然培地のいずれでも使
用可能である。炭素源としては、例えばグリコー
ス、ラフイノース、澱粉等が単独または組合せて
用いられる。さらに菌の資化性によつては、炭化
水素、アルコール類、有機酸も用い得る。窒素源
としては、無機もしくは有機窒素化合物、例えば
塩化アンモニウム、硫酸アンモニウム、硝酸アン
モニウム、尿素、硝酸ナトリウム、グルタミン酸
ナトリウム等、または天然物、例えば大豆粉、酵
母エキス、ペプトン、肉エキス、乾燥酵母、綿実
粕、プロテオースペプトン、カザミノ酸、コー
ン・ステイープ・リカー等が単独または組合せて
用いられる。無機物としては、例えば炭酸カカル
シウム、塩化ナトリウム、硫酸銅、硫酸マンガ
ン、硫酸亜鉛、硫酸鉄等が単独または組合せて用
いられる。その他、S48727株の発育を助け
SS48727Eの生産を促進する物質あるいはシリコ
ン油またはアデカノール(商品名)等の一般的消
泡剤を適宜培地に添加することもできる。培養法
としては、一般の生理活性物質の生産に用いられ
る方法が採用されるが、液体培養法、特に深部撹
拌培養法が最も適している。培養は好気的な条件
で行われ、培養に適当な温度は26〜34℃である
が、一般に27℃付近で培養するのが好ましい。生
理活性物質SS48727Eは振盪培養、深部撹拌培養
法のいずれの場合にもその生産量は〜5日間の培
養で最高に達する。培養液中の生理活性物質
SS48727Eの蓄積量が最高に達した時に培養を停
止し、培養液中から目的物質を単離して精製す
る。
培養液中からのSS48727Eの単離は、後記実施
例に示す如く、本生理活性物質の理化学的性状を
考慮して種々の方法を単独で、あるいは適宜組合
せることによつて行われる。すなわち、生理活性
物質SS48727Eは通常培養濾液及び菌体中に存在
するので培養液を遠心分離または濾過等によつて
菌体を分離し、その菌体及び培養濾液から通常の
分離手段、例えば溶媒油出法、イオン交換樹脂
法、ゲル濾過法、吸着または分配カラムクロマト
法、高速液体クロマト法、透析法、沈澱法などを
単独で、またまたは適宜組合せて生理活性物質
SS48727Eを分離・精製する。
好ましい分離・精製の例としては、次の方法が
挙げれる。醗酵を終了した培養液を遠心分離し、
培養濾液と菌体に分ける。菌体はアセトン、メタ
ノール等適当な溶媒で抽出し、これを減圧下に濃
縮して溶媒を除き水溶液とする。前述の菌体を処
理して得られた濾液とともに、PH7前後で適当な
溶媒、例えば酢酸エチル等で抽出する。抽出液の
溶媒を留去し、n−ヘキサンあるいは石油エーテ
ルで洗つた後、残渣をシリカゲルカラムクロマト
グラフイーに付す。次に適当な溶離液、例えばク
ロロホルム・メタノール混液等で溶出すると、
SS48727E画分が得られる。さらに、SS48727E画
分の溶媒を留去した後、残渣をセフアデツクス
LH20(フアルマシア社製)カラムクロマトグラ
フイーに付す。更に適当な溶離液、例えばメタノ
ールあるいはクロロホルム・メタノール混液等で
溶出、精製すれば生理活性物質SS48727Eの微黄
色無定形晶が得られる。以上の如くして得られた
生理活性物質SS48727Eは次のような理化学的性
質を有する。
<理化学的性質>
元素分析
C H N
実験値(%) 64.21 8.34 2.51
理論値(%) 64.45 8.20 2.42
分子式
C31H47O9N
マススペクトル(FAB−MS)
m/z 578(M+H)+
比旋光度
〔α〕20 D=−10.0゜(C=0.9,メタノール)
紫外線吸収スペクトル
第1図
233(40050)
λHeOH Max(ε)nm, 237(40200)
275(8300)
赤外線吸収スペクトル(KBr法)第2図
1H−NMRスペクトル(90MHz)第3図
重クロロホルム溶液中TMSを基準物質として
測定した。
13C−NMRスペクトル(22.5MHz)
重クロロホルム溶液中TMSを基準物質とし
て測定した。
δ(ppm):155.3(s)154.8(s),151.2(s),
135.8(d),135.8(2s),135.0(s),133.2(d)
,
133.2(s),126.5(d),123.2(d),122.0(d)
,
118.6(s),104.1(d),82.8(d),76.5(d),
75.9(d),74.3(d),70.0(d),61.9(t),60
.9
(q),53.2(q),43.1(t),36.9(d),34.5
(t),
17.4(q),16.6(q),13.1(q),13.0(q),11
.6
(q),10.7(q)
溶解性
クロロホルム、ジメチルスルホキシド、酢酸エ
チル、メタノール、ピリジン、エーテル、アセト
ンに可溶。n−ヘキサン、水に不溶。
塩基性・酸性・中性の区別
中性
物質の色及び性状
微黄色無定形晶
呈色反応
バニリン硫酸試液(加熱)にて陽性。
塩化第2鉄試液及びドラーゲンドルフ
試液にて陰性。
薄層クロマトグラフー
担体:シリカゲルプレートF254(メル
ク社製)[Table] When using carbon sources, + means use, ± means weak use, - means not use.
As shown in the table above, the S48727 strain and Streptomyces carnatakensis IFO 13051 strain are
They differ in the color tone of aerial mycelia, the ability to utilize raffinose, D-fructose, and salicin, and the ability to utilize malic acid and lime. On the other hand, it differs from Streptomyces pactum IFO 13433 strain in its ability to utilize raffinose, D-fructose, and salicin, but has almost the same other mycological properties. Therefore, S48727
The strain was identified as a strain belonging to Streptomyces pactum. In addition, the S48727 strain has the above-mentioned mycological properties and Piericidin A 1 (Piericidin A 1 ).
A1 ), Streptomyces
Streptomyces pactum0-1-10 (Streptomyces pactum0-
1-10) [Nobutaka Takahashi et al., Agricultural and Biological Chemistry, Vol. 41, 849-
pp. 853 and 855-862, (1977)], [Nobutaka Takahashi et al.
A close relationship with JP-A-50-132183] is suggested. However, since strain 0-1-10 does not produce the compound of interest, strain S48727 is considered to be a new strain different from this strain. Therefore, in order to distinguish strain S48727 from known strains, the present inventor named it Streptomyces pactum S48727 and assigned it to the National Institute of Microbiology, Agency of Industrial Science and Technology with accession number. Deposited as No. 8117 (FERM P-8117). The physiologically active substance SS48727E of the present invention is produced by inoculating the above strain into a nutrient-containing medium and culturing it aerobically. As the physiologically active substance SS48727E-producing strain, not only the above-mentioned S48727 strain, but also any artificial or natural mutant strain thereof that has the ability to produce the physiologically active substance SS48727E can be used in the present invention. . the above
The artificial mutant strain S48727 can be easily obtained by, for example, ultraviolet irradiation, cobalt-60 irradiation, chemical mutagen treatment, etc., as in the case of other actinomycetes. Next, the cultivation of the bacterial strain in the production of the physiologically active substance SS48727E will be explained. That is, a normal actinobacterial culture method is used to culture the physiologically active substance SS48727E-producing strain belonging to the genus Streptomyces. As the nutrient medium, any synthetic medium, semi-synthetic medium, or natural medium can be used as long as it contains appropriate amounts of assimilable carbon sources, nitrogen sources, inorganic substances, and the like. As the carbon source, for example, glycose, raffinose, starch, etc. may be used alone or in combination. Furthermore, depending on the assimilation ability of the bacteria, hydrocarbons, alcohols, and organic acids may also be used. Nitrogen sources include inorganic or organic nitrogen compounds, such as ammonium chloride, ammonium sulfate, ammonium nitrate, urea, sodium nitrate, monosodium glutamate, etc., or natural products, such as soybean flour, yeast extract, peptone, meat extract, dried yeast, cottonseed meal. , proteose peptone, casamino acid, corn steep liquor, etc. may be used alone or in combination. As the inorganic substance, for example, calcium carbonate, sodium chloride, copper sulfate, manganese sulfate, zinc sulfate, iron sulfate, etc. are used alone or in combination. In addition, it helps the growth of S48727 strain.
Substances that promote the production of SS48727E or common antifoaming agents such as silicone oil or Adekanol (trade name) can also be added to the medium as appropriate. As the culture method, methods commonly used for the production of physiologically active substances are employed, but liquid culture methods, particularly deep agitation culture methods, are most suitable. Cultivation is performed under aerobic conditions, and the appropriate temperature for cultivation is 26 to 34°C, but it is generally preferable to culture at around 27°C. The production amount of the physiologically active substance SS48727E reaches its maximum after ~5 days of culture in both shaking culture and deep stirring culture methods. Physiologically active substances in culture medium
When the accumulated amount of SS48727E reaches the maximum, the culture is stopped, and the target substance is isolated and purified from the culture solution. SS48727E is isolated from the culture solution by using various methods alone or in appropriate combinations, taking into consideration the physicochemical properties of the physiologically active substance, as shown in the Examples below. That is, since the physiologically active substance SS48727E normally exists in the culture filtrate and bacterial cells, the bacterial cells are separated from the culture solution by centrifugation or filtration, and the bacterial cells and culture filtrate are separated by conventional separation means such as solvent oil. Physiologically active substances can be purified using methods such as extraction method, ion exchange resin method, gel filtration method, adsorption or distribution column chromatography method, high performance liquid chromatography method, dialysis method, precipitation method, etc. alone or in appropriate combinations.
Separate and purify SS48727E. Examples of preferable separation and purification include the following methods. After fermentation, the culture solution is centrifuged,
Separate into culture filtrate and bacterial cells. The bacterial cells are extracted with a suitable solvent such as acetone or methanol, and this is concentrated under reduced pressure to remove the solvent and form an aqueous solution. Together with the filtrate obtained by treating the above-mentioned bacterial cells, the mixture is extracted with a suitable solvent such as ethyl acetate at a pH of around 7. After distilling off the solvent of the extract and washing with n-hexane or petroleum ether, the residue is subjected to silica gel column chromatography. Next, elution with an appropriate eluent, such as a chloroform/methanol mixture, will result in
SS48727E fraction is obtained. Furthermore, after distilling off the solvent of the SS48727E fraction, the residue was
Submit to LH20 (manufactured by Pharmacia) column chromatography. Further elution and purification with a suitable eluent, such as methanol or a chloroform/methanol mixture, yields slightly yellow amorphous crystals of the physiologically active substance SS48727E. The physiologically active substance SS48727E obtained as described above has the following physicochemical properties. <Physical and chemical properties> Elemental analysis C H N Experimental value (%) 64.21 8.34 2.51 Theoretical value (%) 64.45 8.20 2.42 Molecular formula C 31 H 47 O 9 N Mass spectrum (FAB-MS) m/z 578 (M+H) + ratio Optical rotation [α] 20 D = -10.0° (C = 0.9, methanol) Ultraviolet absorption spectrum Fig. 1 233 (40050) λ HeOH Max (ε) nm, 237 (40200) 275 (8300) Infrared absorption spectrum (KBr method) ) Figure 2 1 H-NMR spectrum (90MHz) Figure 3 Measurements were made using TMS in deuterated chloroform solution as a reference substance. 13 C-NMR spectrum (22.5MHz) Measured using TMS in deuterated chloroform solution as a reference substance. δ (ppm): 155.3 (s) 154.8 (s), 151.2 (s), 135.8 (d), 135.8 (2s), 135.0 (s), 133.2 (d)
, 133.2(s), 126.5(d), 123.2(d), 122.0(d)
, 118.6(s), 104.1(d), 82.8(d), 76.5(d), 75.9(d), 74.3(d), 70.0(d), 61.9(t), 60
.9 (q), 53.2 (q), 43.1 (t), 36.9 (d), 34.5
(t), 17.4 (q), 16.6 (q), 13.1 (q), 13.0 (q), 11
.6 (q), 10.7 (q) Solubility Soluble in chloroform, dimethyl sulfoxide, ethyl acetate, methanol, pyridine, ether, and acetone. n-hexane, insoluble in water. Distinction between basic, acidic and neutral Color and properties of the substance Slightly yellow amorphous crystals Color reaction Positive with vanillin sulfuric acid test solution (heated). Negative in ferric chloride test solution and Dragendorff test solution. Thin layer chromatography Support: Silica gel plate F254 (manufactured by Merck)
【表】
構造式
〔作用〕
本発明の生理活性物質SS48727Eは次のような
薬理活性を有する。
抗菌活性
生理活性物質SS48727Eの各種微生物に対する
最小発育阻止濃度(MIC)を第1表に示す。[Table] Structural formula [Effect] The physiologically active substance SS48727E of the present invention has the following pharmacological activities. Antibacterial activity Table 1 shows the minimum inhibitory concentration (MIC) of the physiologically active substance SS48727E against various microorganisms.
【表】【table】
【表】
降圧作用
本発明化合物SS48727Eの降圧作用を次のよう
にして調べた。すなわちウイスター(Wistar)
系雄性ラツトをウレタン(1g/Kgi.p.)で麻酔
後、背位に固定し、気管カニユーレを挿入して気
道を確保した。少量のジメチルスルホキシドで本
発明化物SS48727Eを溶解せしめた後、生理食塩
液で適宜希釈し、これを被検薬剤として上記ラツ
トの大腿静脈内に投与した。被検ラツトの大腿動
脈から圧トランスデユーサーを介して血圧
(blood pressure)を、第1誘導法により心電図
を、また心電図のR−R間隔をトリガー
(trigger)として瞬時心拍計により心拍数
(heart rate)を測定し、いずれもポリグラフ上
に記録した。この結果を第2表に示す。[Table] Hypotensive effect The hypotensive effect of the present compound SS48727E was investigated as follows. i.e. Wistar
After a male rat was anesthetized with urethane (1 g/Kgi.p.), it was fixed in a dorsal position, and a tracheal cannula was inserted to secure the airway. The compound of the present invention SS48727E was dissolved in a small amount of dimethyl sulfoxide, diluted appropriately with physiological saline, and administered into the femoral vein of the rat as a test drug. The blood pressure was measured from the femoral artery of the test rat via a pressure transducer, the electrocardiogram was measured using the first lead method, and the heart rate was measured using an instantaneous heart rate monitor using the R-R interval of the electrocardiogram as a trigger. rate) and recorded on a polygraph. The results are shown in Table 2.
これまで発見されたピエリシジン群
(Piericidins)と構造的に比較した場合、
SS48727EはC3′位の水酸基にD−グルコースを有
するので毒性の低下が期待される。
一方、SS48727Eはグラム陽性菌、白癬菌及び
イモチ菌に対し抗菌作用を有することより抗生物
質あるいは農薬として有用である。
また、持続的降圧作用を示すことから医薬とし
ても有用である。
〔実施例〕
次に実施例を挙げて説明する。
実施例
グルコース1%、溶性澱粉1%、ポリペプトン
0.5%、肉エキス0.5%、酵母エキス0.3%、塩化ナ
トリウム0.3%、硫酸マグネシウム0.1%、炭酸カ
ルシウム0.3%、硫酸銅0.0007%、硫酸第1鉄
0.0001%、硫酸マンガン0.0008%、硫酸亜鉛
0.0002%の組成を有する液体培地をPH7.0とし、
500ml容坂口ララスコに100ml分注して滅菌する。
これにストレプトミセス パクタム S48727株
(微工研菌寄第8117号)を接種し、27℃で2日間
振盪培養して種培養液を作成する。次に、グルコ
ース2%、プロテオースペプトン1%、硫酸銅
0.0007%、硫酸第1鉄0.0001%、硫酸マンガン
0.0008%、硫酸亜鉛0.0002%の組成を有する液体
培地をPH6.5とし、30容ジヤーフアメンターに
18仕込み滅菌する。これに前記の種培養液180
mlを接種し、培養温度27℃、撹拌数350rpm、通
気量18/分の条件下で90時間培養する。なお、
培養の際のPH上昇を防ぐために、5規定酢酸によ
りPH7.5に調整した。また、発泡を防止するため
に適宜アデカノール(商品名)を添加した。かく
して得られた培養液を遠心分離することにより菌
体と培養濾液に分離し、菌体はメタノール5を
加え撹拌後濾過し、得られた濾液を40℃で約1/10
容まで減圧濃縮した。次にこの濃縮液に等量の水
を加え酢酸エチル2で2回抽出した。一方培養
濾液も2倍量の酢酸エチルで2回抽出し、先の菌
体の抽出液と合せて40℃で溶媒を減圧留去し油状
の粗抽出物を得た。この粗抽出物をn−ヘキサン
で洗つて得られた油状の粗抽出物15.6gをシリカ
ゲル(メルク社製KieselGel60,230〜400メツシ
ユ)カラムクロマトグラフイー4.0(φ)×50cmに
付し、クロロホルム/メタノール(98:2)混液
2で溶出すればすみやかにピエリシジンA1
(Piericidin A1)が溶出する。さらに同じく
(96:4)混液4で溶出すれば最初にSS48727B
画分が溶出し、次にそれとよく分離して
SS48727E画分45mgが溶出した。さらにSS48727E
画分をセフアデツクスLH20(フアルマシア社製)
カラムクロマトグラフイー2.0(φ)×55cmに付し、
メタノールで溶出して微黄色無定形晶の
SS48727Eの純品20mgを得た。
本物質は前記した理化学的性質を有しているこ
とを確かめた。
When compared structurally with the piericidins discovered so far,
Since SS48727E has D-glucose in the hydroxyl group at the C3 ' position, it is expected to have reduced toxicity. On the other hand, SS48727E has an antibacterial effect against Gram-positive bacteria, Trichophyton, and Grocerycus, and is therefore useful as an antibiotic or agricultural chemical. It is also useful as a medicine because it exhibits a sustained hypotensive effect. [Example] Next, an example will be given and explained. Example 1% glucose, 1% soluble starch, polypeptone
0.5%, meat extract 0.5%, yeast extract 0.3%, sodium chloride 0.3%, magnesium sulfate 0.1%, calcium carbonate 0.3%, copper sulfate 0.0007%, ferrous sulfate
0.0001%, manganese sulfate 0.0008%, zinc sulfate
A liquid medium with a composition of 0.0002% has a pH of 7.0,
Dispense 100ml into a 500ml volume Sakaguchi Lalasco and sterilize.
This is inoculated with Streptomyces pactum S48727 strain (Feikoken Bacterium No. 8117) and cultured with shaking at 27°C for 2 days to prepare a seed culture. Next, glucose 2%, proteose peptone 1%, copper sulfate
0.0007%, ferrous sulfate 0.0001%, manganese sulfate
A liquid medium with a composition of 0.0008% and 0.0002% zinc sulfate was adjusted to pH 6.5 and placed in a 30 volume jar fermenter.
18Prepare and sterilize. Add 180% of the above seed culture solution to this.
ml was inoculated and cultured for 90 hours at a culture temperature of 27°C, stirring rate of 350 rpm, and air flow rate of 18/min. In addition,
In order to prevent the pH from increasing during culture, the pH was adjusted to 7.5 using 5N acetic acid. In addition, ADEKA NOL (trade name) was appropriately added to prevent foaming. The culture solution obtained in this way is separated into bacterial cells and culture filtrate by centrifugation, and the bacterial cells are mixed with 5 methanol and filtered after stirring.
The mixture was concentrated under reduced pressure to volume. Next, an equal amount of water was added to this concentrated solution, and the mixture was extracted twice with 2 portions of ethyl acetate. On the other hand, the culture filtrate was also extracted twice with twice the amount of ethyl acetate, combined with the previous bacterial cell extract, and the solvent was distilled off under reduced pressure at 40°C to obtain an oily crude extract. This crude extract was washed with n-hexane, and 15.6 g of the oily crude extract obtained was subjected to silica gel (Merck Kiesel Gel 60, 230-400 mesh) column chromatography 4.0 (φ) x 50 cm, and chloroform/ Piericidin A 1 can be quickly eluted with methanol (98:2) mixture 2.
(Piericidin A 1 ) is eluted. Furthermore, if you elute with the same (96:4) mixture 4, SS48727B will appear first.
The fraction is eluted and then well separated from
45 mg of SS48727E fraction was eluted. Further SS48727E
Sephadex LH20 (manufactured by Pharmacia)
Attach to column chromatography 2.0 (φ) x 55cm,
Elution with methanol yields slightly yellow amorphous crystals.
20 mg of pure SS48727E was obtained. It was confirmed that this substance has the above-mentioned physical and chemical properties.
第1図は本発明の生理活性物質SS48727Eの紫
外線吸収スペクトル、第2図は同赤外線吸収スペ
クトル、第3図は同1H−NMRスペクトルをそれ
ぞれ示す図面である。
FIG. 1 shows the ultraviolet absorption spectrum, FIG. 2 shows the infrared absorption spectrum, and FIG. 3 shows the 1 H-NMR spectrum of the physiologically active substance SS48727E of the present invention.
Claims (1)
質SS48727E生産菌を培養し、その培養液から生
理活性物質SS48727Eを採取することを特徴とす
る新規生理活性物質SS48727Eの製造法。 3 SS48727E生産菌がストレプトミセスパクタ
ムS48727(Streptomyces pactum S48727)であ
る特許請求の範囲第2項記載の製造法。[Claims] 1. SS48727E is a novel physiologically active substance expressed by SS48727E. 2. A method for producing a novel physiologically active substance SS48727E, which comprises culturing a novel physiologically active substance SS48727E-producing bacterium belonging to the genus Streptomyces and collecting the physiologically active substance SS48727E from the culture solution. 3. The production method according to claim 2, wherein the SS48727E producing bacterium is Streptomyces pactum S48727.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13472485A JPS61291594A (en) | 1985-06-20 | 1985-06-20 | Novel physiologically active substance ss48727e and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13472485A JPS61291594A (en) | 1985-06-20 | 1985-06-20 | Novel physiologically active substance ss48727e and production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61291594A JPS61291594A (en) | 1986-12-22 |
JPH0359911B2 true JPH0359911B2 (en) | 1991-09-12 |
Family
ID=15135117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13472485A Granted JPS61291594A (en) | 1985-06-20 | 1985-06-20 | Novel physiologically active substance ss48727e and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61291594A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02312586A (en) * | 1989-05-26 | 1990-12-27 | Snow Brand Milk Prod Co Ltd | New physiologically active substance sn-198c-forming bacterium, new physiologically active substance sn-198c and its production |
-
1985
- 1985-06-20 JP JP13472485A patent/JPS61291594A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS61291594A (en) | 1986-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900004066B1 (en) | Process for the preparation of biologically active ws 6049 | |
EP0004128A1 (en) | Frenolicin B, process for preparation thereof and pharmaceutical compositions containing it | |
JPH0359911B2 (en) | ||
JPH0359910B2 (en) | ||
JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
JPH0625095B2 (en) | Antibiotic SF-2415 substance and its production method | |
JPS6015318B2 (en) | New antibiotic SF-1942 substance, its manufacturing method and anticancer agent containing it | |
JPS6135788A (en) | Physiologically active substance ss20846a and its preparation | |
JPH08239379A (en) | Kr 2827 derivative as new substance, its production and use | |
JPS59170092A (en) | Novel antibiotic, ss8201d and its preparation | |
JPH0366308B2 (en) | ||
JP4235298B2 (en) | Antibiotic pareic acid A and its production method | |
JP2594085B2 (en) | SF2575, a new antitumor antibiotic, and method for producing the same | |
JPH0259596A (en) | Novel substance, utilization and production thereof | |
JPS62228074A (en) | Substance ss50408 and production thereof | |
JPS6269992A (en) | Antibiotic ss42227a and production thereof | |
JPH0585998A (en) | New compounds ca39-a and ca39-b, their use and production | |
JPS6265692A (en) | Production of leptomycin a | |
JPH08165286A (en) | Antibiotic tetromycin a and b, and its production | |
JPH0637519B2 (en) | Novel antibiotic globopeptin and method for producing the same | |
JP2001055386A (en) | Antibiotic tubelactomicin b, d and e, and production thereof | |
JPH01265893A (en) | Novel substance k3619, use and production thereof | |
JPS5942894A (en) | Physiologically active substance ss 12538c and its preparation | |
JPS61115081A (en) | Novel antibiotic ss21020d and production thereof | |
JPH02221292A (en) | New substance 02-3, its use and production thereof |